Preventative Health
Transformative technologies in imaging, genetics, immunotherapy, stem cells, senolytics, and info-nomics are coming, and will revolutionize healthcare, and possibly significantly slow aging in our lifetime. While promising, and of much interest, for the moment many of these technologies remain very expensive and the risk/ reward tradeoffs of using them have yet to be well defined. In other words, they are still just out of reach, but optimizing what we can, to ensure we are here and vital when these breakthroughs arrive is a key part of a practical longevity strategy in 2022/2023.
Heart disease and cancers that should be screened or prevented continue to shorten our healthy lifespans. Diet and exercise recommendations remain confusing and are often not evidence based or incoherent. Genetic screening with actionable results is already useful and only getting better.
These are low-hanging fruit that are important complements to life-extension strategies.
My objective is to remain vigilant for meaningful new developments, and incorporate them when the evidence is strong enough to seriously consider, and ensure that you have the information you need to optimizing for risk factors that we already know about and can control.
Transformative technologies in imaging, genetics, immunotherapy, stem cells, senolytics, and info-nomics are coming, and will revolutionize healthcare, and possibly significantly slow aging in our lifetime. While promising, and of much interest, for the moment many of these technologies remain very expensive and the risk/ reward tradeoffs of using them have yet to be well defined. In other words, they are still just out of reach, but optimizing what we can, to ensure we are here and vital when these breakthroughs arrive is a key part of a practical longevity strategy in 2022/2023.
Heart disease and cancers that should be screened or prevented continue to shorten our healthy lifespans. Diet and exercise recommendations remain confusing and are often not evidence based or incoherent. Genetic screening with actionable results is already useful and only getting better.
These are low-hanging fruit that are important complements to life-extension strategies.
My objective is to remain vigilant for meaningful new developments, and incorporate them when the evidence is strong enough to seriously consider, and ensure that you have the information you need to optimizing for risk factors that we already know about and can control.
